SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001103021-22-000004
Filing Date
2022-01-20
Accepted
2022-01-20 08:05:37
Documents
14
Period of Report
2022-01-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsi-20220120.htm   iXBRL 8-K 43960
2 EX-99.1 bdsiq4preannouncement_0120.htm EX-99.1 34676
6 image_0.jpg GRAPHIC 34037
  Complete submission text file 0001103021-22-000004.txt   271752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsi-20220120.xsd EX-101.SCH 1878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsi-20220120_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsi-20220120_pre.xml EX-101.PRE 12492
8 EXTRACTED XBRL INSTANCE DOCUMENT bdsi-20220120_htm.xml XML 11222
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 22540704
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences